Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.
Veillon P, Payan C, Picchio G, Maniez-Montreuil M, Guntz P, Lunel F. Veillon P, et al. Among authors: payan c. J Clin Microbiol. 2003 Jul;41(7):3212-20. doi: 10.1128/JCM.41.7.3212-3220.2003. J Clin Microbiol. 2003. PMID: 12843066 Free PMC article.
Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen.
Lunel F, Veillon P, Fouchard-Hubert I, Loustaud-Ratti V, Abergel A, Silvain C, Rifflet H, Blanchi A, Causse X, Bacq Y, Payan C; Fontevraud Study Group. Lunel F, et al. Among authors: payan c. J Hepatol. 2003 Nov;39(5):826-33. doi: 10.1016/s0168-8278(03)00402-1. J Hepatol. 2003. PMID: 14568267 Clinical Trial.
[Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol].
Pivert A, Payan C, Lunel F; Conseil Scientifique de RIBAVIC. Pivert A, et al. Among authors: payan c. Pathol Biol (Paris). 2004 Nov;52(9):522-8. doi: 10.1016/j.patbio.2004.07.036. Pathol Biol (Paris). 2004. PMID: 15531116 French.
Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin.
Pivert A, Payan C, Morand P, Fafi-Kremer S, Deshayes J, Carrat F, Pol S, Cacoub P, Perronne C, Lunel F. Pivert A, et al. Among authors: payan c. J Clin Microbiol. 2006 Feb;44(2):417-22. doi: 10.1128/JCM.44.2.417-422.2006. J Clin Microbiol. 2006. PMID: 16455894 Free PMC article. Clinical Trial.
Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies.
Laperche S, Saune K, Dény P, Duverlie G, Alain S, Chaix ML, Gaudy C, Lunel F, Pawlotsky JM, Payan C, Pozzetto B, Tamalet C, Thibault V, Vallet S, Bouchardeau F, Izopet J, Lefrère JJ. Laperche S, et al. Among authors: payan c. J Clin Microbiol. 2006 Feb;44(2):614-6. doi: 10.1128/JCM.44.2.614-616.2006. J Clin Microbiol. 2006. PMID: 16455925 Free PMC article.
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, Lunel-Fabiani F, Bouviers-Alias M, Trimoulet P, Chaix ML, Hézode C, Foucher J, Fontaine H, Roque-Afonso AM, Gassin M, Schvoerer E, Gaudy C, Roche B, Doffoël M, D'Alteroche L, Vallet S, Baazia Y, Pozzetto B, Thibault V, Nousbaum JB, Roulot D, Coppere H, Poynard T, Payan C, Izopet J. Legrand-Abravanel F, et al. Among authors: payan c. J Med Virol. 2009 Dec;81(12):2029-35. doi: 10.1002/jmv.21583. J Med Virol. 2009. PMID: 19856464 Free article.
Duplication of the V3 domain in hepatitis C virus (1b) NS5A protein: Clonal analysis and physicochemical properties related to hepatocellular carcinoma occurrence.
Petsaris O, Vallet S, Le Guillou-Guillemette H, Veillon P, Gouriou S, Barbier G, Nousbaum JB, Saliou P, NKontchou G, Trinchet JC, Lunel-Fabiani F, Payan C. Petsaris O, et al. Among authors: payan c. J Clin Virol. 2016 Jan;74:19-25. doi: 10.1016/j.jcv.2015.11.011. Epub 2015 Dec 1. J Clin Virol. 2016. PMID: 26655076
Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma.
Le Guillou-Guillemette H, Pivert A, Bouthry E, Henquell C, Petsaris O, Ducancelle A, Veillon P, Vallet S, Alain S, Thibault V, Abravanel F, Rosenberg AA, André-Garnier E, Bour JB, Baazia Y, Trimoulet P, André P, Gaudy-Graffin C, Bettinger D, Larrat S, Signori-Schmuck A, Saoudin H, Pozzetto B, Lagathu G, Minjolle-Cha S, Stoll-Keller F, Pawlotsky JM, Izopet J, Payan C, Lunel-Fabiani F, Lemaire C. Le Guillou-Guillemette H, et al. Among authors: payan c. PLoS One. 2017 Apr 10;12(4):e0174651. doi: 10.1371/journal.pone.0174651. eCollection 2017. PLoS One. 2017. PMID: 28394908 Free PMC article.
223 results